Yüklüyor......
Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial
BACKGROUND: CD73 is an ecto-enzyme that promotes tumor immune escape through the production of immunosuppressive extracellular adenosine in the tumor microenvironment. Several CD73 inhibitors and adenosine receptor antagonists are being evaluated in phase I clinical trials. PATIENTS AND METHODS: Ful...
Kaydedildi:
| Yayımlandı: | Ann Oncol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5913595/ https://ncbi.nlm.nih.gov/pubmed/29145561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdx730 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|